Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Antony J, Hemmelgarn B, Moher D, Hutton B, Straus SE.

Syst Rev. 2013 Jun 28;2:46. doi: 10.1186/2046-4053-2-46.

2.
3.

Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis.

Tricco AC, Blondal E, Veroniki AA, Soobiah C, Vafaei A, Ivory J, Strifler L, Cardoso R, Reynen E, Nincic V, Ashoor H, Ho J, Ng C, Johnson C, Lillie E, Antony J, Roberts DJ, Hemmelgarn BR, Straus SE.

BMC Med. 2016 Dec 23;14(1):216. doi: 10.1186/s12916-016-0761-9. Review.

5.

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

Tricco AC, Soobiah C, Hui W, Antony J, Struchkov V, Hutton B, Hemmelgarn B, Moher D, Straus SE.

BMC Pharmacol Toxicol. 2015 Jan 26;16:1. doi: 10.1186/2050-6511-16-1. Review.

6.

Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.

Salvo N, Doble B, Khan L, Amirthevasar G, Dennis K, Pasetka M, Deangelis C, Tsao M, Chow E.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):408-17. doi: 10.1016/j.ijrobp.2010.08.060. Epub 2010 Nov 13. Review.

PMID:
21075553
7.

Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, Ivory J, Strifler L, Ashoor H, MacDonald H, Reynen E, Robson R, Ho J, Ng C, Antony J, Mrklas K, Hutton B, Hemmelgarn BR, Moher D, Straus SE.

BMC Med. 2015 Jun 18;13:142. doi: 10.1186/s12916-015-0379-3. Review.

8.

Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, Ivory J, Strifler L, Ashoor H, MacDonald H, Reynen E, Robson R, Ho J, Ng C, Antony J, Mrklas K, Hutton B, Hemmelgarn BR, Moher D, Straus SE.

BMC Med. 2015 Jun 18;13:136. doi: 10.1186/s12916-015-0371-y. Review.

9.

Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.

Tricco AC, Ashoor HM, Soobiah C, Hemmelgarn B, Moher D, Hutton B, Yu CH, Majumdar SR, Straus SE.

Syst Rev. 2013 Sep 10;2:73. doi: 10.1186/2046-4053-2-73.

10.

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S.

Cochrane Database Syst Rev. 2015 Nov 12;(11):CD009464. doi: 10.1002/14651858.CD009464.pub2. Review.

PMID:
26561338
11.

Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Phillips RS, Friend AJ, Gibson F, Houghton E, Gopaul S, Craig JV, Pizer B.

Cochrane Database Syst Rev. 2016 Feb 2;2:CD007786. doi: 10.1002/14651858.CD007786.pub3. Review.

PMID:
26836199
12.

Use of cognitive enhancers for mild cognitive impairment: protocol for a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Lillie E, Perrier L, Chen MH, Hemmelgarn B, Majumdar SR, Straus SE.

Syst Rev. 2012 May 30;1:25. doi: 10.1186/2046-4053-1-25.

13.

Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis.

Tricco AC, Vandervaart S, Soobiah C, Lillie E, Perrier L, Chen MH, Hemmelgarn B, Majumdar SR, Straus SE.

Syst Rev. 2012 Jun 28;1:31. doi: 10.1186/2046-4053-1-31.

14.

Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.

dos Santos LV, Souza FH, Brunetto AT, Sasse AD, da Silveira Nogueira Lima JP.

J Natl Cancer Inst. 2012 Sep 5;104(17):1280-92. doi: 10.1093/jnci/djs335. Epub 2012 Aug 21. Review.

PMID:
22911671
15.

Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis.

Tricco AC, Antony J, Soobiah C, Hemmelgarn B, Moher D, Hutton B, Yu CH, Majumdar SR, Straus SE.

Syst Rev. 2013 Jun 28;2:47. doi: 10.1186/2046-4053-2-47.

16.

Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.

Jin Y, Sun W, Gu D, Yang J, Xu Z, Chen J.

Eur J Cancer Care (Engl). 2013 Jan;22(1):41-50. doi: 10.1111/j.1365-2354.2012.01353.x. Epub 2012 Apr 22. Review.

PMID:
22519361
17.

Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.

Simino GP, Marra LP, Andrade EI, Acúrcio Fde A, Reis IA, De Araújo VE, Cherchiglia ML.

Expert Rev Clin Pharmacol. 2016 Sep;9(9):1183-94. doi: 10.1080/17512433.2016.1190271. Epub 2016 Jun 15. Review.

PMID:
27180992
18.

Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.

Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K, Pizer B.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007786. doi: 10.1002/14651858.CD007786.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;2:CD007786.

PMID:
20824866
19.

Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysis.

Tricco AC, Antony J, Angeliki VA, Ashoor H, Hutton B, Hemmelgarn BR, Moher D, Finkelstein Y, Gough K, Straus SE.

Syst Rev. 2014 May 25;3:51. doi: 10.1186/2046-4053-3-51. Review.

20.

Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.

Tramèr MR, Reynolds DJ, Stoner NS, Moore RA, McQuay HJ.

Eur J Cancer. 1998 Nov;34(12):1836-44.

PMID:
10023303

Supplemental Content

Support Center